STICHTING LYGATURE -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:700-800
Total Number of Projects:500-600
2018
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 17
As coordinator: 2
As participant: 15
Sole participant: 0
Coordinator / Participant Ratio: 0.13*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2023 0 4.640.205 110.313 1
2022 0 7.814.549 382.500 1
2021 0 153.557.805 5.143.751 5
2020 0 4.000.000 117.620 1
2019 12.299.995 44.032.603 2.125.696 1 5
2018 18.249.993 5.357.033 1.619.944 1 1
2016 0 11.000.000 1.345.962 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
NOVARTIS PHARMA6
STICHTING VUMC6
BAYER5
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM5
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V5
UCB BIOPHARMA5
ACADEMISCH ZIEKENHUIS GRONINGEN4
ASTRAZENECA4
EATRIS ERIC4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
KING'S COLLEGE LONDON4
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS4
TAKEDA PHARMACEUTICALS INTERNATIONAL4
UNIVERSITE DU LUXEMBOURG4
UNIVERSITY OF OSLO4
UPPSALA UNIVERSITET4
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CENTRE DE REGULACIO GENOMICA3
CONSIGLIO NAZIONALE DELLE RICERCHE3
CSC TIETEEN TIETOTEKNIIKAN KESKUS OY3
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM3
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS3
F HOFFMANNLA ROCHE3
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON3
KAROLINSKA INSTITUTE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
MASARYKOVA UNIVERZITA3
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN3
PFIZER LIMITED3
SANOFIAVENTIS3
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
ALBERT LUDWIGS UNIVERSITAET FREIBURG2
ALZHEIMER EUROPE2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
ELI LILLY AND COMPANY LIMITED2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
EUROBIOIMAGING ERIC2
EUROPEAN CANCER PATIENT COALITION2
EUROPEAN INFRASTRUCTURE OF OPEN SCREENING PLATFORMS FOR CHEMICAL BIOLOGY EUROPEAN RESEARCH INFRASTUCTURE CONSORTIUM2
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA2
FUNDACIO INSTITUT DE RECERCA BIOMEDICA2
INFRAFRONTIER2
INSTITUTO DE SAUDE PUBLICA DA UNIVERSIDADE DO PORTO2
INSTRUCTERIC2
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW2
MEDIZINISCHE UNIVERSITAET WIEN2
SEMMELWEIS UNIVERSITY OF MEDICINE2
SOFTWARE2
STICHTING DTL PROJECTS2
SYDDANSK UNIVERSITET2
TARTU ULIKOOL2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED2
THE HYVE BV2
THE UNIVERSITY OF LIVERPOOL2
THE UNIVERSITY OF NOTTINGHAM2
TTOPSTART BV2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITEIT MAASTRICHT2
UNIVERSITY OF DUNDEE2
UNIVERZA V LJUBLJANI2
UNIVERZITA PALACKEHO V OLOMOUCI2
VIB VZW2
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER2
AC IMMUNE1
ALLEANZA CONTRO IL CANCRO1
ALLERGAN LIMITED1
ALTOIDA1
ANTAROS MEDICAL AB1
ARIDHIA INFORMATICS LIMITED1
ASTRAZENECA AB1
AZIENDA OSPEDALIERA PER L EMERGENZA CANNIZZARO1
BAYER AKTIENGESELLSCHAFT1
BIOASCENT DISCOVERY LIMITED1
BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE1
BIOGEN IDEC LIMITED1
BMD SOFTWARE LDA1
CENTRE D'ETUDE ET DE RECHERCHES VETERINAIRES ET AGROCHIMIQUES1
CENTRE DE RECHERCHE PUBLIC DE LA SANTE1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO DI RICERCA SVILUPPO E STUDI SUPERIORI IN SARDEGNA SOCIETA A RESPONSABILITA LIMITATA1
CESSDA ERIC1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHARLES RIVER DISCOVERY RESEARCH SERVICES GERMANY1
CHARLES UNIVERSITY PRAGUE1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
COVANCE CLINICAL AND PERIAPPROVAL SERVICES1
CRITICAL PATH INSTITUTE LIMITED1

Constancy:

Total number of partners: 416
Partner loyalty:
Frequent Partner: (> 2 projects): 148
Rare Partner: 268
Frequent / Rare Partner Ratio: 0.55

Project overview:

Start dateProjectacronymrolefundingpartners
2023-01-01Prioritization, incentives and Resource use for sUstainable DENTistry PRUDENTparticipant4.640.20512
2022-09-01A European-wide foundation to accelerate Data-driven Cancer Research EOSC4Cancerparticipant7.814.54934
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-10-01Beyond COVID BY-COVIDparticipant12.000.00053
2021-07-01Building a reproducible single-cell experimental workflow to capture tumour drug persistence PERSIST-SEQparticipant7.057.98016
2021-06-01ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS UNITE4TBparticipant92.500.00032
2021-02-01Central Repository for Digital Pathology BIGPICTUREparticipant32.319.82551
2020-06-01Beyond 1M Genomes B1MGparticipant4.000.00037
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-07-01NOVEL GRAM-NEGATIVE ANTIBIOTIC NOW GNA NOWcoordinator12.299.99511
2019-05-01Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug PD-MINDparticipant999.69810
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2019-01-01Remote Assessment of Disease and Relapse – Alzheimer’s Disease RADAR-ADparticipant4.999.75717
2018-12-01European Screening Centre; Unique Library for Attractive Biology ESCulabcoordinator18.249.99320
2018-01-01NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION RESTOREparticipant5.357.0338
2016-04-01Remote Assessment of Disease and Relapse in Central Nervous System Disorders - Sofia ref.: 115902 RADAR-CNSparticipant11.000.00025